Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Transplant Immunology|March 29, 2011
The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantationMaud D'Aveni, Lamia Aïssi-Rothé, Véronique Venard, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapyLamia Aïssi-Rothé, Véronique Decot, Véronique Venard, et al.Leukemia & Lymphoma|June 8, 2017
Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 studyMauricette Michallet, Mohamad Sobh, Frederic Garban, et al.Oncotarget|April 2, 2016
High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationTomasz Czerw, Myriam Labopin, Christoph Schmid, et al.Haematologica|March 30, 2013
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Ambroise Marcais, Raphael Porcher, Marie Robin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 11, 2015
Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell TherapiesRomain Guièze, Gandhi Damaj, Bruno Pereira, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2009
Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie CellulaireAnne Sirvent, Nathalie Dhedin, Mauricette Michallet, et al.Journal of Hematology & Oncology|May 10, 2017
Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trialChongsheng Qian, Arnaud Campidelli, Yingying Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des MyélodysplasiesGandhi Damaj, Alain Duhamel, Marie Robin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trialBernard Rio, Sylvie Chevret, Stéphane Vigouroux, et al.Pageof 3